Not sure this would be apparent to new investors b
Post# of 1418
You may want to interrupt the sentence below to say most of the things forsale in the machine, Todos will get 100% of their cut which is around $12 an item. I would imagine only for Tollovid products, profit would be split 52%. So most of the revenue & profit will be Todos. This cash cow will enable Todos to move from cash flow positive to highly profitable with high revenue. The best part is, machine installs start in a month. Not a year from now or some far off timeline. Somewhere between now and then, the market will figure it out.
Quote:
Gerald Commissiong@G_Commish 3h
The machine will be full of a variety of products most without Tollovid. We manufacture those as well. So the facility does CBD now and we will be adding Tollovid to it. We expect somewhere around a 30% monthly turnover although $50M is at 5%.
At 30% turnover that would be $31,680,000 for the initial stock and...
$9,504,000 a month
So ongoing beyond the $31M, $114M a year